ArticleNucleic acids research2006
EPD in its twentieth year: towards complete promoter coverage of selected model organisms.
Article in Nucleic acids research, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
57 citing papers in PubMed, 132 citations in OpenAlex.
- Genomic benchmarks: a collection of datasets for genomic sequence classification.BMC genomic data · 2023Article
- Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.PLoS genetics · 2017Article
- Computational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines.Frontiers in genetics · 2016Article
- Sequence information gain based motif analysis.BMC bioinformatics · 2015Article
- Genome-wide methylated CpG island profiles of melanoma cells reveal a melanoma coregulation network.Scientific reports · 2013Article
- MEF2 is an in vivo immune-metabolic switch.Cell · 2013Article
- Gene promoters show chromosome-specificity and reveal chromosome territories in humans.BMC genomics · 2013Article
- Genome-wide computational prediction and analysis of core promoter elements across plant monocots and dicots.PloS one · 2013Article
- P-value-based regulatory motif discovery using positional weight matrices.Genome research · 2013Article
- Role of helicase-like transcription factor (hltf) in the G2/m transition and apoptosis in brain.PloS one · 2013Article
- Rapid identification of novel functional promoters for gene therapy.Journal of molecular medicine (Berlin, Germany) · 2012Article
- Eukaryotic genomes may exhibit up to 10 generic classes of gene promoters.BMC genomics · 2012Article
- Classification of human genomic regions based on experimentally determined binding sites of more than 100 transcription-related factors.Genome biology · 2012Article
- Optimizing the GATA-3 position weight matrix to improve the identification of novel binding sites.BMC genomics · 2012Article
- DREM 2.0: Improved reconstruction of dynamic regulatory networks from time-series expression data.BMC systems biology · 2012Article
- ReLA, a local alignment search tool for the identification of distal and proximal gene regulatory regions and their conserved transcription factor binding sites.Bioinformatics (Oxford, England) · 2012Article
- LCGbase: A Comprehensive Database for Lineage-Based Co-regulated Genes.Evolutionary bioinformatics online · 2012Article
- Article
- Article
- Aberrant DNA methylation and prostate cancer.Current genomics · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Eukaryotic Promoter Database (EPD) is an annotated non-redundant collection of eukaryotic POL II promoters, experimentally defined by a transcription start site (TSS). Access to promoter sequences is provided by pointers to positions in the corresponding genomes. Promoter evidence comes from conventional TSS mapping experiments for individual genes, or, starting from release 73, from mass genome annotation projects. Subsets of promoter sequences with customized 5' and 3' extensions can be downloaded from the EPD website. The focus of current development efforts is to reach complete promoter coverage for important model organisms as soon as possible. To speed up this process, a new class of preliminary promoter entries has been introduced as of release 83, which requires less stringent admission criteria. As part of a continuous integration process, new web-based interfaces have been developed, which allow joint analysis of promoter sequences with other bioinformatics resources developed by our group, in particular programs offered by the Signal Search Analysis Server, and gene expression data stored in the CleanEx database. EPD can be accessed at http://www.epd.isb-sib.ch.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.